Tag: New schizophrenia drug for Alzheimer’s patients

alzheimers-dentified-as-key-market-for-bristol-myers-squibbs-new-schizophrenia-drug

Alzheimer’s Identified as Key Market for Bristol Myers Squibb’s New Schizophrenia Drug

Business News -
**Alzheimer's Identified as Key Market for Bristol Myers Squibb's New Schizophrenia Drug**In a groundbreaking move, Bristol Myers Squibb has set its sights on revolutionizing the treatment landscape for Alzheimer's disease with its newly approved...
Read more
© Market Trends & Economy Updates